Cite Filings / AMRX / 0001193125-23-273645

Feed Companies Filings Check

Sign in

S-8 POS

Post-effective Amendment

Amneal Pharmaceuticals, Inc. Filed 2023-11-08 Acc 0001193125-23-273645

Documents 1

S-8 POS Post-effective Amendment , d536921ds8pos.htm

Around this filing

2023-11-08 4 10% owner acquired 53,578,209 shares (other)
2023-11-08 4 Director acquired 17,497,336 shares (other)
2023-11-08 4 Member of 13D Group acquired 26,905,073 shares (other)
2023-11-08 4 President & Co-CEO acquired 21,269,420 shares (other)
2023-11-08 4 Co-CEO acquired 24,753,252 shares (other)
2023-11-08 S-8 POS Post-effective Amendment
2023-11-08 S-8 POS Post-effective Amendment

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading d536921ds8pos.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…